Background. Klebsiella pneumoniae is a common colonizer of the gastrointestinal tract of humans, companion animals, and livestock. To better understand potential contributions of foodborne K.

Introduction and objectives: infection by Enterobacteriaceae which are resistant to carbapenems is challenging problem in health care centers. The correct monitoring of patients for treatment by ...

The procedures for the isolation and identification of the micro-organisms involved were the same as the ones used in our previous studies. 3 They conform to those recommended by Edwards and Ewing. 23 ...

Fetroja® (cefiderocol) has been made available by Shionogi for the treatment of complicated urinary tract infections (cUTI), including pyelonephritis caused by the following susceptible Gram-negative ...

The Food and Drug Administration (FDA) has approved Fetroja (cefiderocol; Shionogi) for the treatment of complicated urinary tract infections (cUTI), including pyelonephritis caused by the following ...

man-injection-0316 The antibiotic Recarbrio is a combination of imipenem-cilastatin and relebactam. The FDA today approved Recarbrio, an antibiotic injection containing a combination of ...

A new bacteriophage-based rapid test has the potential to identify the specific pathogen causing a urinary tract infection (UTI) at the point of care, enabling targeted use of antibiotics. The test ...

The U.S. Food and Drug Administration has granted approval to a new antibiotic to treat urinary tract infections in women and adolescent girls. The drug is made by British pharmaceutical company GSK.

Researchers release an open-access phage library targeting Klebsiella, accelerating global efforts to combat rising antibiotic resistance.